Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes

Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes

The incidence and prevalence of diabetes are increasing worldwide, and cardiovascular disease (CVD) is the leading cause of death among subjects with type 2 diabetes (T2D). The assessment and stratification of cardiovascular risk in subjects with T2D is a challenge. Advanced glycation end products a...

Full description

Bibliographic Details
Main Authors:	Alejandra Planas, Olga Simó-Servat, Cristina Hernández, Rafael Simó
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	International Journal of Molecular Sciences
Subjects:	cardiovascular disease advanced glycation end products diabetic retinopathy cardiovascular disease biomarkers type 2 diabetes diabetic complications
Online Access:	https://www.mdpi.com/1422-0067/23/11/6234

Similar Items

Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients
by: Alejandra Planas, et al.
Published: (2021-12-01)

Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives
by: Jing Liu, et al.
Published: (2023-12-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Glycated albumin modifies platelet adhesion and aggregation responses
by: Ioana Soaita, et al.
Published: (2017-10-01)

Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease
by: Raphael S. Pinto, et al.
Published: (2022-02-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy
by: Leqaa A. Moemen, et al.
Published: (2020-04-01)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
by: Tomoka Nakamura, et al.
Published: (2023-06-01)

Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus
by: Irene Carrión-Barberà, et al.
Published: (2024-03-01)

Exercise, Advanced Glycation End Products, and Their Effects on Cardiovascular Disorders: A Narrative Review
by: Saeedeh Hosseini Hooshiar, et al.
Published: (2022-01-01)

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
by: Jing Xu, et al.
Published: (2018-07-01)

Relationship of advanced glycation end-products in hypertension in diabetic patients: a systematic review
by: Joana Cortelete Fuhr, et al.
Published: (2022-10-01)

The cardiovascular complications of diabetes: a striking link through protein glycation
by: Ahmad Mousa Numan, et al.
Published: (2020-12-01)

Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease
by: Li WY, et al.
Published: (2022-10-01)

Evaluation of Relevance between Advanced Glycation End Products and Diabetic Retinopathy Stages Using Skin Autofluorescence
by: Yuji Takayanagi, et al.
Published: (2020-11-01)

Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
by: Mariyam Khalid, et al.
Published: (2022-04-01)

Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

The role of advanced glycation end products in patogenesis of diabetic nephropathy
by: A. O. Gavrilova, et al.
Published: (2022-01-01)

Skin Autofluorescence–Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All‐Cause Mortality in High‐Risk Subjects: A Systematic Review and Meta‐analysis
by: Ivan Cavero‐Redondo, et al.
Published: (2018-09-01)

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
by: Jinluan Chen, et al.
Published: (2023-11-01)

Skin autofluorescence as an indicator of advanced glycation end-product accumulation in the prognosis of age-related cardiovascular disease: literature review
by: Petr A. Lebedev, et al.
Published: (2023-06-01)

Skin accumulation of advanced glycation end products and cardiovascular risk in Korean patients with type 2 diabetes mellitus
by: Lee-Seoul Choi, et al.
Published: (2022-06-01)

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
by: Toshiyuki Oshitari
Published: (2023-02-01)

Serum Advanced Glycation End Products and Their Soluble Receptor as New Biomarkers in Systemic Lupus Erythematosus
by: Irene Carrión-Barberà, et al.
Published: (2024-03-01)

Inhibition of Advanced Glycation End Products and NADPH Oxidase by <i>Cirsium japonicum</i> in Streptozotocin-Induced Diabetic Rats
by: Jihye Choi, et al.
Published: (2024-03-01)

Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
by: Jeongmin Lee, et al.
Published: (2022-07-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Advanced glycation end products of dietary origin and their association with inflammation in diabetes – A minireview
by: Pedreanez Adriana, et al.
Published: (2024-01-01)

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes
by: James N. Tsoporis, et al.
Published: (2020-11-01)

ADVANCED GLYCATION END PRODUCTS AND THEIR RECEPTORS IN CARDIOVASCULAR DISEASES
by: Shevtsova A. I., et al.
Published: (2019-03-01)

Chronic ocular small vessel disease: An overview of diabetic retinopathy and its relationship with cardiovascular health
by: Siva S.R. Iyer, et al.
Published: (2023-05-01)

Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study
by: Po Chung Cheng, et al.
Published: (2017-10-01)

Advanced Glycation End-Products in Blood Serum—Novel Ischemic Stroke Risk Factors? Implication for Diabetic Patients
by: Aleksandra Kuzan, et al.
Published: (2024-01-01)

Advanced Glycation End Products in Health and Disease
by: V. Prakash Reddy, et al.
Published: (2022-09-01)

Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts
by: Julio A. Lamprea‐Montealegre, et al.
Published: (2022-08-01)

Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
by: Yanyan Kong, et al.
Published: (2020-07-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
by: Sarah Louise Fishman, et al.
Published: (2018-11-01)